Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/SC/Myrtle Beach
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Myrtle Beach, SC

Studies commonly pay $75 to $4,500 per completed study

86 clinical trials are currently recruiting participants within 30 miles of Myrtle Beach. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

86studies recruiting
6+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Myrtle Beach right now

Top 25 of 86 recruiting studies, sorted by proximity — each links to its official registry page

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Steba Biotech S.A.

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Cataract Phase 3 Interventional 528 participants sought
Conway Ophthalmology — Conway, South Carolina (12.8 mi) · Sponsor: Melt Pharmaceuticals

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Prostate Cancer (Adenocarcinoma), Prostate CA Phase 2 Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Cellvax Therapeutics Inc

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Janssen Research & Development, LLC

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Asthma Phase 3 Interventional 724 participants sought
Teva Investigational Site 12111 — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Teva Branded Pharmaceutical Products R&D LLC

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Phase 3 Interventional 250 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Ferring Pharmaceuticals

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Novartis Pharmaceuticals

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Prostate Cancer Phase 3 Interventional 940 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Novartis Pharmaceuticals

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Non-muscle Invasive Bladder Cancer Phase 1 Interventional 294 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Carolina Regional Cancer Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: NRG Oncology

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma Phase 3 Interventional 284 participants sought
START - Carolinas — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Protara Therapeutics

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Prostate Cancer, Prostatic Neoplasms Phase 3 Interventional 383 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Clarity Pharmaceuticals Ltd

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Low-grade NMIBC, FGFR Gene Amplification Phase 2 Interventional 90 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Tyra Biosciences, Inc

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms Phase 1, Phase 2 Interventional 235 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Janssen Research & Development, LLC

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Prostate Cancer Phase 2 Interventional 900 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Astellas Pharma Global Development, Inc.

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Metastatic Castration-resistant Prostate Cancer Phase 3 Interventional 670 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

Hidradenitis Suppurativa Phase 3 Interventional 550 participants sought
Investigative Site US041 — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Incyte Corporation

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

Prostate Cancer Phase 1, Phase 2 Interventional 300 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma) Phase 2 Interventional 45 participants sought
START Carolinas — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Candel Therapeutics, Inc.

STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking

Tobacco Use, Substance Use Disorders N/A Interventional 240 participants sought
Shoreline Behavioral Health Services — Conway, South Carolina (12.8 mi) · Sponsor: Medical University of South Carolina

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer Phase 2 Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Hoffmann-La Roche
Google-rated

Top-rated research centers in Myrtle Beach

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

START Carolinas

★ 4.7
823 82nd Pkwy suite b, Myrtle Beach, SC 29572
(843) 839-1679
"Initial conference for stone removal. Didn’t learn anything I hadn’t already learned from the internet. In a holding pattern for surgery scheduling."
— Happy Jack, 4★

Advanced Clinical Trials

★ 5.0
291 SC-90 #291e, Little River, SC 29566
(843) 249-4129

Body Revolution Aesthetics & Wellness

★ 5.0
1211 48th Ave N, Myrtle Beach, SC 29577
(843) 213-1633

Coastal Carolina Research Center

★ 4.4
4920 O'Hear Ave Ste 101, North Charleston, SC 29405
(843) 856-3784
"I feel Coastal Carolina is a valuable asset to the research community in the Charleston area. They are extremely welcoming and professional. Their ex…"
— Pam, 5★

Little River Medical Center

★ 4.4
4220 Carolina Exchange Dr, Myrtle Beach, SC 29579
(843) 663-8000
"Dr. Insignares is a great face for LRMC. With him, it is all about the patient—like it used to be!"
— ElizabethT, 5★

Clinical Research Center Of The Carolinas

1364 Ashley River Rd, Charleston, SC 29407
(843) 375-8111

Clinical trials in Myrtle Beach: what's recruiting

The Myrtle Beach area currently has 86 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Myrtle Beach, the most active research areas are:

  • Cancer & Oncology16 studies
  • Liver & Kidney1 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Myrtle Beach, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Myrtle Beach

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Myrtle Beach participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Myrtle Beach pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Myrtle Beach, SC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Myrtle Beach?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Myrtle Beach typically complete one or two studies per year.

Paid clinical trials near Myrtle Beach

Other metros within reach

More of SC

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts